New York, NY — October 23, 2025
Biolux Technology, the developer of OrthoPulse®, today announced a nationwide expansion of strategic partnerships with leading Dental and Orthodontic Support Organizations (DSOs/OSOs). This initiative aims to scale the adoption of OrthoPulse—a game-changing, AI-powered technology—across group practices to elevate patient care, operational efficiency, and profitability.
OrthoPulse uses near-infrared light therapy (NIR) which has been proven in multiple clinical studies* to accelerate tooth movement, reduce discomfort, and support overall oral health, including periodontal improvement and post-treatment bone remodeling during the retention phase. Backed by robust clinical evidence and FDA clearance, OrthoPulse is increasingly becoming the standard of care for both aligner and bracket-based orthodontic treatment.
“OrthoPulse is transforming how we deliver care—it's faster, more comfortable for patients, and provides lasting oral health benefits,” said Dr. Mark Coreil, Orthodontist. “We’re seeing not only shorter treatment times, but also healthier tissue and improved bone stability post-treatment. It’s a must-have for modern orthodontics.”
AI-Driven Platform Enhancing Patient and Provider Experience
OrthoPulse goes beyond a device—it’s a digital platform designed for scalable, intelligent care:
Patient App: Improves compliance with daily usage tracking and automated reminders
Doctor Portal: Offers real-time insights into patient progress and adherence
Compliance Monitoring: Enables predictable outcomes and early intervention
This connected ecosystem empowers orthodontic teams to deliver consistent, high-quality care across locations while engaging patients more effectively.
Driving Growth for Group Practices
OrthoPulse also delivers measurable business value for group practices:
Increased Revenue: Boosts case acceptance and average selling price (ASP)
Improved EBITDA: Enhances operational efficiency with streamlined workflows
Simplified Integration: Supports standardized protocols across multi-location networks
Biolux is actively collaborating with DSO/OSO procurement teams to incorporate OrthoPulse into bundled treatment offerings and clinical pathways.
“We’re not just scaling a device—we’re scaling smarter orthodontics,” said Michael Hendricks, Head of U.S. at Biolux Technology. “By partnering with top DSOs and OSOs, we’re embedding OrthoPulse into everyday workflows—improving patient outcomes, boosting revenue, and setting a new standard in orthodontic care.”
About Biolux Technology
Biolux Technology is a global leader in non-invasive light therapy devices for dental and orthodontic applications. Its flagship product, OrthoPulse, is FDA-cleared and CE-marked, supporting thousands of practices worldwide. Biolux is committed to advancing orthodontic care through innovation, data-driven platforms, and collaborative partnerships. Learn more: orthopulse.com
*Studies done with OrthoPulse as well as photobiomodulation studies available upon request.
Media Contact: Michael Hendricks, Chief Business Officer at Biolux Technology USA LLC, m.hendricks@bioluxtec.com, 917-340-1651